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graph should be included in the library of anyone interested in pulmonary
disease.
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There is a tendency amongst writers of reviews to quote their own work
extensively, to pontificate pompously, to cluck cliches, to commit catachresis
in order to achieve alliteration and to build up long sentences with too
many clauses. It is therefore a pleasure to find that this fourth annual
collection of review articles is highly readable, without an excess of these
faults. Nineteen authors range over the frontiers of pharmacology from
allergy to venoms, with a strong emphasis upon mechanisms-biochemical,
receptor, absorption and excretion, structure-action, and metabolic. In ad-
dition, the book starts with an autobiographical outline of the career of E.
Rothlin and ends with a "must" for those wishing to gain a quick entree into
specialized literature-a "Review of reviews" by C. D. Leake.
Criticisms of this volume are mainly related to the mechanics of review
production. Some authors completed their survey in March, 1963 while
others took until September. Thus, those who presumably met the dead-
line suffer by having reviews published which are more than a year out-
of-date before they reach the reader. This time lapse could surely be
cut by several months.
Signs of sloppy editing are shown in the number of typographical errors
and in the lack of standardization of the format and of abbreviations for
journal names in the references and in mistakes in the author index.
In the subject matter of the individual reviews, there is a considerable
degree of overlapping, especially in the field of the autonomic nervous sys-
tem. Thus, there are six chapters dealing in some part with the storage,
release and action of catecholamines. These chapters also serve to illus-
trate what is perhaps the only major criticsm of the volume, and that is the
apparant patriotism of some of the authors in their reading habits. J. R.
Cooper (Yale) in his chapter on the biochemical mechanisms of drug
action relies on American authors or journals for 80%o of his references
and D. Aviado (Pennsylvania) gives the impression that 85%o of cardio-
vascular pharmacology is prosecuted in the United States. On the heart,
B. H. Marks (Ohio) is 63%o American, whereas on smooth muscle, E. E.
Daniel (Alberta) is only 42%o, on structure-action relationships, F. N.
Fastier (Otago) is only 46%o and on the autonomic nervous system,
E. Zaimis (London, England) is only 40%o. In view of these geographical
tendencies, it is perhaps fortunate that the subject matter does overlap.
There is one other statistic of note. J. Axelrod (Bethesda) has the honor
of being quoted most often by the reviewers (23 citations in six separate
chapters), more often even than they quote themselves. On this basis alone,
he has my vote for "pharmacologist of the year."
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